# SOLACEA-H in Heparin-sparing Haemodialysis

> **NCT06281028** · NA · RECRUITING · sponsor: **GCS Ramsay Santé pour l'Enseignement et la Recherche** · enrollment: 19 (estimated)

## Conditions studied

- Dialysis Membrane Reaction

## Interventions

- **DEVICE:** SOLACEA-H/HYDROLINK-NVU
- **DEVICE:** HYDROLINK-NVU/SOLACEA-H

## Key facts

- **NCT ID:** NCT06281028
- **Lead sponsor:** GCS Ramsay Santé pour l'Enseignement et la Recherche
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06281028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06281028, "SOLACEA-H in Heparin-sparing Haemodialysis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06281028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*